BioSpace News Archive

United Therapeutics Corporation announced that the U.S. Food and Drug Administration has accepted for review the New Drug Application for Trevyent® for the treatment of pulmonary arterial hypertension.

Anokion SA announced the acquisition of Kanyos Bio, Inc. and the completion of a $40 million Series B financing.

China SXT Pharmaceuticals, Inc. announced that it has been granted to establish the Taizhou Research Center for Advanced TCMP Engineering Techniques by the Taizhou Science and Technology Bureau, a department of the Taizhou city government.

The nomination of industry experts is expected to support the company’s management in execution of its product development and commercialization roadmap

ActivOrtho, Inc., having recently received 510 clearance by the FDA to market the Continuous Compression Screw System, announced its first human clinical implant.

Creative Medical Technology Holdings (OTC-CELZ) reported today it has signed an agreement with Edge Media Network to introduce CaverStem® to their community in an integrated campaign spanning web, email, social media, and in-person events.

DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused on the development of novel cancer therapies, today announced that CEO Saiid Zarrabian will deliver a presentation on the Company and meet with investors at the Fall Investor Summit on September 16, 2019 at 1:30 PM ET in Track 1 at Essex House, 160 Central Park South in New York City

Mr. Beaudouin will remain with the company in an advisory role prior to retiring at the end of the year.

Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company pioneering a new way to treat the underlying cause of genetic diseases by precisely upregulating protein expression, today announced that it has been added to the Russell 2000® and 3000® indexes effective September 20, 2019

CTD is also a proud sponsor of the conference, for the 4th year running